United States Allergy Immunotherapies Market Report 2017

January 2017 | 112 pages | ID: U1CDAD71D1AEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Allergy Immunotherapies

Revenue, means the sales value of Allergy Immunotherapies

This report studies sales (consumption) of Allergy Immunotherapies in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Adamis Pharmaceuticals
• Aimmune Therapeutics
• Anergis
• ASIT biotech
• Biomay
• Circassia
• DBV Technologies
• Genentech
• HAL Allergy
• Laboratorios LETI
• Mitsubishi Tanabe Pharma
• Nycomed
• Sementis
• Shionogi
• Torii
• Tunitas Therapeutics
• VentiRx Pharmaceuticals
• Verona Pharma

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Subcutaneous immunotherapy
• Sublingual Immunotherapy

Split by applications, this report focuses on sales, market share and growth rate of Allergy Immunotherapies in each application, can be divided into

• Allergic Rhinitis
• Allergic Asthma
• Other

Contents

United States Allergy Immunotherapies Market Report 2017

1 ALLERGY IMMUNOTHERAPIES OVERVIEW

1.1 Product Overview and Scope of Allergy Immunotherapies
1.2 Classification of Allergy Immunotherapies
  1.2.1 Subcutaneous immunotherapy
  1.2.2 Sublingual Immunotherapy
1.3 Application of Allergy Immunotherapies
  1.3.1 Allergic Rhinitis
  1.3.2 Allergic Asthma
  1.3.3 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Allergy Immunotherapies (2011-2021)
  1.4.1 United States Allergy Immunotherapies Sales and Growth Rate (2011-2021)
  1.4.2 United States Allergy Immunotherapies Revenue and Growth Rate (2011-2021)

2 UNITED STATES ALLERGY IMMUNOTHERAPIES COMPETITION BY MANUFACTURERS

2.1 United States Allergy Immunotherapies Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Allergy Immunotherapies Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Allergy Immunotherapies Average Price by Manufactures (2015 and 2016)
2.4 Allergy Immunotherapies Market Competitive Situation and Trends
  2.4.1 Allergy Immunotherapies Market Concentration Rate
  2.4.2 Allergy Immunotherapies Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ALLERGY IMMUNOTHERAPIES SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Allergy Immunotherapies Sales and Market Share by States (2011-2016)
3.2 United States Allergy Immunotherapies Revenue and Market Share by States (2011-2016)
3.3 United States Allergy Immunotherapies Price by States (2011-2016)

4 UNITED STATES ALLERGY IMMUNOTHERAPIES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Allergy Immunotherapies Sales and Market Share by Type (2011-2016)
4.2 United States Allergy Immunotherapies Revenue and Market Share by Type (2011-2016)
4.3 United States Allergy Immunotherapies Price by Type (2011-2016)
4.4 United States Allergy Immunotherapies Sales Growth Rate by Type (2011-2016)

5 UNITED STATES ALLERGY IMMUNOTHERAPIES SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Allergy Immunotherapies Sales and Market Share by Application (2011-2016)
5.2 United States Allergy Immunotherapies Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES ALLERGY IMMUNOTHERAPIES MANUFACTURERS PROFILES/ANALYSIS

6.1 Adamis Pharmaceuticals
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Allergy Immunotherapies Product Type, Application and Specification
    6.1.2.1 Subcutaneous immunotherapy
    6.1.2.2 Sublingual Immunotherapy
  6.1.3 Adamis Pharmaceuticals Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Aimmune Therapeutics
  6.2.2 Allergy Immunotherapies Product Type, Application and Specification
    6.2.2.1 Subcutaneous immunotherapy
    6.2.2.2 Sublingual Immunotherapy
  6.2.3 Aimmune Therapeutics Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Anergis
  6.3.2 Allergy Immunotherapies Product Type, Application and Specification
    6.3.2.1 Subcutaneous immunotherapy
    6.3.2.2 Sublingual Immunotherapy
  6.3.3 Anergis Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 ASIT biotech
  6.4.2 Allergy Immunotherapies Product Type, Application and Specification
    6.4.2.1 Subcutaneous immunotherapy
    6.4.2.2 Sublingual Immunotherapy
  6.4.3 ASIT biotech Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Biomay
  6.5.2 Allergy Immunotherapies Product Type, Application and Specification
    6.5.2.1 Subcutaneous immunotherapy
    6.5.2.2 Sublingual Immunotherapy
  6.5.3 Biomay Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Circassia
  6.6.2 Allergy Immunotherapies Product Type, Application and Specification
    6.6.2.1 Subcutaneous immunotherapy
    6.6.2.2 Sublingual Immunotherapy
  6.6.3 Circassia Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 DBV Technologies
  6.7.2 Allergy Immunotherapies Product Type, Application and Specification
    6.7.2.1 Subcutaneous immunotherapy
    6.7.2.2 Sublingual Immunotherapy
  6.7.3 DBV Technologies Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Genentech
  6.8.2 Allergy Immunotherapies Product Type, Application and Specification
    6.8.2.1 Subcutaneous immunotherapy
    6.8.2.2 Sublingual Immunotherapy
  6.8.3 Genentech Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 HAL Allergy
  6.9.2 Allergy Immunotherapies Product Type, Application and Specification
    6.9.2.1 Subcutaneous immunotherapy
    6.9.2.2 Sublingual Immunotherapy
  6.9.3 HAL Allergy Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Laboratorios LETI
  6.10.2 Allergy Immunotherapies Product Type, Application and Specification
    6.10.2.1 Subcutaneous immunotherapy
    6.10.2.2 Sublingual Immunotherapy
  6.10.3 Laboratorios LETI Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Mitsubishi Tanabe Pharma
6.12 Nycomed
6.13 Sementis
6.14 Shionogi
6.15 Torii
6.16 Tunitas Therapeutics
6.17 VentiRx Pharmaceuticals
6.18 Verona Pharma

7 ALLERGY IMMUNOTHERAPIES MANUFACTURING COST ANALYSIS

7.1 Allergy Immunotherapies Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Allergy Immunotherapies

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Allergy Immunotherapies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Allergy Immunotherapies Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ALLERGY IMMUNOTHERAPIES MARKET FORECAST (2016-2021)

11.1 United States Allergy Immunotherapies Sales, Revenue Forecast (2016-2021)
11.2 United States Allergy Immunotherapies Sales Forecast by Type (2016-2021)
11.3 United States Allergy Immunotherapies Sales Forecast by Application (2016-2021)
11.4 Allergy Immunotherapies Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Allergy Immunotherapies
Table Classification of Allergy Immunotherapies
Figure United States Sales Market Share of Allergy Immunotherapies by Type in 2015
Figure Subcutaneous immunotherapy Picture
Figure Sublingual Immunotherapy Picture
Table Application of Allergy Immunotherapies
Figure United States Sales Market Share of Allergy Immunotherapies by Application in 2015
Figure Allergic Rhinitis Examples
Figure Allergic Asthma Examples
Figure Other Examples
Figure United States Allergy Immunotherapies Sales and Growth Rate (2011-2021)
Figure United States Allergy Immunotherapies Revenue and Growth Rate (2011-2021)
Table United States Allergy Immunotherapies Sales of Key Manufacturers (2015 and 2016)
Table United States Allergy Immunotherapies Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Allergy Immunotherapies Sales Share by Manufacturers
Figure 2016 Allergy Immunotherapies Sales Share by Manufacturers
Table United States Allergy Immunotherapies Revenue by Manufacturers (2015 and 2016)
Table United States Allergy Immunotherapies Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Allergy Immunotherapies Revenue Share by Manufacturers
Table 2016 United States Allergy Immunotherapies Revenue Share by Manufacturers
Table United States Market Allergy Immunotherapies Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Allergy Immunotherapies Average Price of Key Manufacturers in 2015
Figure Allergy Immunotherapies Market Share of Top 3 Manufacturers
Figure Allergy Immunotherapies Market Share of Top 5 Manufacturers
Table United States Allergy Immunotherapies Sales by States (2011-2016)
Table United States Allergy Immunotherapies Sales Share by States (2011-2016)
Figure United States Allergy Immunotherapies Sales Market Share by States in 2015
Table United States Allergy Immunotherapies Revenue and Market Share by States (2011-2016)
Table United States Allergy Immunotherapies Revenue Share by States (2011-2016)
Figure Revenue Market Share of Allergy Immunotherapies by States (2011-2016)
Table United States Allergy Immunotherapies Price by States (2011-2016)
Table United States Allergy Immunotherapies Sales by Type (2011-2016)
Table United States Allergy Immunotherapies Sales Share by Type (2011-2016)
Figure United States Allergy Immunotherapies Sales Market Share by Type in 2015
Table United States Allergy Immunotherapies Revenue and Market Share by Type (2011-2016)
Table United States Allergy Immunotherapies Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Allergy Immunotherapies by Type (2011-2016)
Table United States Allergy Immunotherapies Price by Type (2011-2016)
Figure United States Allergy Immunotherapies Sales Growth Rate by Type (2011-2016)
Table United States Allergy Immunotherapies Sales by Application (2011-2016)
Table United States Allergy Immunotherapies Sales Market Share by Application (2011-2016)
Figure United States Allergy Immunotherapies Sales Market Share by Application in 2015
Table United States Allergy Immunotherapies Sales Growth Rate by Application (2011-2016)
Figure United States Allergy Immunotherapies Sales Growth Rate by Application (2011-2016)
Table Adamis Pharmaceuticals Basic Information List
Table Adamis Pharmaceuticals Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Adamis Pharmaceuticals Allergy Immunotherapies Sales Market Share (2011-2016)
Table Aimmune Therapeutics Basic Information List
Table Aimmune Therapeutics Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aimmune Therapeutics Allergy Immunotherapies Sales Market Share (2011-2016)
Table Anergis Basic Information List
Table Anergis Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Anergis Allergy Immunotherapies Sales Market Share (2011-2016)
Table ASIT biotech Basic Information List
Table ASIT biotech Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
Table ASIT biotech Allergy Immunotherapies Sales Market Share (2011-2016)
Table Biomay Basic Information List
Table Biomay Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biomay Allergy Immunotherapies Sales Market Share (2011-2016)
Table Circassia Basic Information List
Table Circassia Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Circassia Allergy Immunotherapies Sales Market Share (2011-2016)
Table DBV Technologies Basic Information List
Table DBV Technologies Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
Table DBV Technologies Allergy Immunotherapies Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Allergy Immunotherapies Sales Market Share (2011-2016)
Table HAL Allergy Basic Information List
Table HAL Allergy Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
Table HAL Allergy Allergy Immunotherapies Sales Market Share (2011-2016)
Table Laboratorios LETI Basic Information List
Table Laboratorios LETI Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Laboratorios LETI Allergy Immunotherapies Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Basic Information List
Table Nycomed Basic Information List
Table Sementis Basic Information List
Table Shionogi Basic Information List
Table Torii Basic Information List
Table Tunitas Therapeutics Basic Information List
Table VentiRx Pharmaceuticals Basic Information List
Table Verona Pharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Allergy Immunotherapies
Figure Manufacturing Process Analysis of Allergy Immunotherapies
Figure Allergy Immunotherapies Industrial Chain Analysis
Table Raw Materials Sources of Allergy Immunotherapies Major Manufacturers in 2015
Table Major Buyers of Allergy Immunotherapies
Table Distributors/Traders List
Figure United States Allergy Immunotherapies Production and Growth Rate Forecast (2016-2021)
Figure United States Allergy Immunotherapies Revenue and Growth Rate Forecast (2016-2021)
Table United States Allergy Immunotherapies Production Forecast by Type (2016-2021)
Table United States Allergy Immunotherapies Consumption Forecast by Application (2016-2021)
Table United States Allergy Immunotherapies Sales Forecast by States (2016-2021)
Table United States Allergy Immunotherapies Sales Share Forecast by States (2016-2021)